Requirement of inositol 1,4,5-trisphosphate receptors for tumor-mediated lymphocyte apoptosis

Journal of Biological Chemistry

Volumn 283, Issue 20, 2008, Pages 13506-13509

  Steinmann, Camia ^a   Landsverk, Megan L ^b   Barral, José M ^a   Boehning, Darren ^a,c  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOLS; ANIMAL CELL CULTURE; CALCIUM; CALCIUM ALLOYS; CELL DEATH; SUGARS; TUMORS;

APOPTOSIS; APOPTOTIC CELL DEATHS; CALCIUM RELEASES; COLON CANCER CELLS; FAS LIGANDS; JURKAT CELLS; LYMPHOMA CELLS; RECEPTOR EXPRESSIONS; SPECIFIC INHIBITORS; T LYMPHOCYTES; TRIS PHOSPHATES; TUMOR CELLS;

INTERNET PROTOCOLS;

CALCIUM ION; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; FAS ANTIGEN; FAS LIGAND; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; XESTOSPONGIN C; CALCIUM; CASPASE 3; PEPTIDE;

APOPTOSIS; ARTICLE; CALCIUM TRANSPORT; CANCER CELL CULTURE; CELL STRAIN SW620; CONTROLLED STUDY; DRUG MECHANISM; DRUG TARGETING; HUMAN; HUMAN CELL; IMMUNOGENICITY; LEUKEMIA CELL LINE; LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; TUMOR IMMUNOLOGY; BIOLOGICAL MODEL; CHEMISTRY; IMMUNE SYSTEM; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY; RNA INTERFERENCE; T LYMPHOCYTE; TUMOR CELL LINE;

ANTIGENS, CD95; APOPTOSIS; CALCIUM; CASPASE 3; CELL LINE, TUMOR; HUMANS; IMMUNE SYSTEM; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; JURKAT CELLS; LYMPHOCYTES; MODELS, BIOLOGICAL; NEOPLASMS; PEPTIDES; RNA INTERFERENCE; T-LYMPHOCYTES;

EID: 46649097078     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.C800029200     Document Type: Article

References (19)

1. Reichmann, E. (2002) Semin. Cancer Biol. 12, 309-315
2. Houston, A., and O'Connell, J. (2004) Curr. Opin. Pharmacol. 4, 321-326
3. Ryan, A. E., Shanahan, F., O'Connell, J., and Houston, A. M. (2006) Cell Cycle 5, 246-249
4. O'Connell, J., Houston, A., Bennett, M. W., O'Sullivan, G. C., and Shanahan, F. (2001) Nat. Med. 7, 271-274
5. Houston, A., Waldron-Lynch, F. D., Bennett, M. W., Roche, D., O'Sullivan, G. C., Shanahan, F., and O'Connell, J. (2003) Int. J. Cancer 107, 209-214
6. Bebenek, M., Dus, D., and Kozlak, J. (2006) Med. Sci. Monit. 12, CR457-CR461
7. Yamana, K., Bilim, V., Hara, N., Kasahara, T., Itoi, T., Maruyama, R., Nishiyama, T., Takahashi, K., and Tomita, Y. (2005) Br. J. Cancer 93, 544-551
8. Reimer, T., Koczan, D., Muller, H., Friese, K., Thiesen, H. J., and Gerber, B. (2002) Breast Cancer Res. 4, R9
9. Ryan, A. E., Shanahan, F., O'Connell, J., and Houston, A. M. (2005) Cancer Res. 65, 9817-9823
10. Bennett, M. W., O'Connell, J., Houston, A., Kelly, J., O'Sullivan, G. C., Collins, J. K., and Shanahan, F. (2001) J. Clin. Pathol. (Lond). 54, 598-604
11. Houston, A., Bennett, M. W., O'Sullivan, G. C., Shanahan, F., and O'Connell, J. (2003) Br. J. Cancer 89, 1345-1351
12. Wozniak, A. L., Wang, X., Stieren, E. S., Scarbrough, S. G., Elferink, C. J., and Boehning, D. (2006) J. Cell Biol. 175, 709-714
13. Boehning, D., Patterson, R. L., Sedaghat, L., Glebova, N. O., Kurosaki, T., and Snyder, S. H. (2003) Nat. Cell Biol. 5, 1051-1061
14. Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tomaselli, K. J., Debatin, K. M., Krammer, P. H., and Peter, M. E. (1998) EMBO J. 17, 1675-1687
15. Boehning, D., van Rossum, D. B., Patterson, R. L., and Snyder, S. H. (2005) Proc. Natl. Acad. Sci. U. S. A. 102, 1466-1471
16. O'Connell, J., O'Sullivan, G. C., Collins, J. K., and Shanahan, F. (1996) J. Exp. Med. 184, 1075-1082
17. Gafni, J., Munsch, J. A., Lam, T. H., Catlin, M. C., Costa, L. G., Molinski, T. F., and Pessah, I. N. (1997) Neuron 19, 723-733
18. Ta, T. A., Feng, W., Molinski, T. F., and Pessah, I. N. (2006) Mol. Pharmacol. 69, 532-538
19. Igney, F. H., and Krammer, P. H. (2005) Cancer Immunol. Immunother. 54, 1127-1136